HEADER MEMBRANE PROTEIN 24-SEP-17 6B3U TITLE SOLUTION STRUCTURE OF HIV-1 GP41 TRANSMEMBRANE DOMAIN IN BICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 GP41 TRANSMEMBRANE DOMAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: POLYPEPTIDE SEQUENCE FOR THE SOLUTION STRUCTURE COMPND 6 CORRESPONDS TO GP160 (677-716; HXB2 NUMBERING). SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: ENV; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS HIV-1, TRANSMEMBRANE DOMAIN, GP41, SOLUTION STRUCTURE, RESIDUAL KEYWDS 2 DIPOLAR COUPLINGS, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR S.C.CHILIVERI,J.M.LOUIS,R.GHIRLANDO,J.L.BABER,A.BAX REVDAT 3 14-JUN-23 6B3U 1 REMARK REVDAT 2 25-DEC-19 6B3U 1 REMARK REVDAT 1 24-JAN-18 6B3U 0 JRNL AUTH S.C.CHILIVERI,J.M.LOUIS,R.GHIRLANDO,J.L.BABER,A.BAX JRNL TITL TILTED, UNINTERRUPTED, MONOMERIC HIV-1 GP41 TRANSMEMBRANE JRNL TITL 2 HELIX FROM RESIDUAL DIPOLAR COUPLINGS. JRNL REF J. AM. CHEM. SOC. V. 140 34 2018 JRNL REFN ESSN 1520-5126 JRNL PMID 29277995 JRNL DOI 10.1021/JACS.7B10245 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6B3U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1000230228. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 318 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 25 REMARK 210 PRESSURE : 1 BAR REMARK 210 SAMPLE CONTENTS : 500 UM [U-100% 13C; U-100% 15N; REMARK 210 U-100% 2H] HIV-1 GP41 REMARK 210 TRANSMEMBRANE DOMAIN, 93% H2O/7% REMARK 210 D2O; 100 UM [U-100% 15N; 80%-2H] REMARK 210 HIV-1 GP41 TRANSMEMBRANE DOMAIN, REMARK 210 93% H2O/7% D2O; 100 UM [U-100% REMARK 210 15N; 80%-2H] HIV-1 GP41 REMARK 210 TRANSMEMBRANE DOMAIN, 93% H2O/7% REMARK 210 D2O; 40 UM [U-100% 15N; U-80% 2H] REMARK 210 HIV-1 GP41 TRANSMEMBRANE DOMAIN, REMARK 210 93% H2O/7% D2O; 70 UM [U-100% REMARK 210 15N; U-80% 2H] HIV-1 GP41 REMARK 210 TRANSMEMBRANE DOMAIN, 93% H2O/7% REMARK 210 D2O; 300 UM [U-100% 15N; U-80% REMARK 210 2H] HIV-1 GP41 TRANSMEMBRANE REMARK 210 DOMAIN, 93% H2O/7% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCO; 3D HNCA; 3D 1H-15N REMARK 210 NOESY; 2D TROSY; 2D ARTSY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II; AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR, X-PLOR NIH, NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 60 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 GLN A 710 98.18 -161.58 REMARK 500 4 GLN A 710 84.92 54.12 REMARK 500 5 TYR A 712 -88.28 54.09 REMARK 500 6 SER A 713 39.30 -151.23 REMARK 500 7 SER A 713 -62.26 -104.62 REMARK 500 15 GLN A 710 -172.53 50.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30349 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF HIV-1 GP41 TRANSMEMBRANE DOMAIN IN BICELLES DBREF 6B3U A 677 716 UNP Q74849 Q74849_9HIV1 670 709 SEQRES 1 A 40 ASN TRP LEU TRP TYR ILE ARG ILE PHE ILE ILE ILE VAL SEQRES 2 A 40 GLY SER LEU ILE GLY LEU ARG ILE VAL PHE ALA VAL LEU SEQRES 3 A 40 SER LEU VAL ASN ARG VAL ARG GLN GLY TYR SER PRO LEU SEQRES 4 A 40 SER HELIX 1 AA1 TRP A 678 ARG A 709 1 32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1